-
1
Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player i...
Published 2024-10-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
2
Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
Published 2023-07-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
3
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Published 2018-06-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
4
Occult hepatitis B virus infection: clearance or disguise?
Published 2014-09-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
5
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
Published 2023-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
6
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
Published 2016-09-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
7
Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steato hepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internis...
Published 2019-12-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
8
A decade of liver organoids: Advances in disease modeling
Published 2023-07-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
9
Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
Published 2018-09-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
10
History and future of hepatitis B virus control in South Korea
Published 2021-10-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
11
Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Published 2024-07-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
12
Cost-of-illness studies: concepts, scopes, and methods
Published 2014-12-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
13
Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
Published 2020-10-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
14
Deep learning assisted biomarker development in patients with chronic hepatitis B: Editorial on “Prognostic role of computed tomography analysis using deep learning algorithm in pa...
Published 2024-10-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
15
Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
Published 2014-09-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
16
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Published 2023-02-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
17
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
Published 2017-06-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
18
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
Published 2020-07-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
19
Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma
Published 2012-09-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
20
The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
Published 2017-03-01“…Clinical and Molecular Hepatology…”
Get full text
Article